Where are you?
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Singapore
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.
You are viewing as from Change

Liontrust US Opportunities Fund

Q3 2021 review
Past performance does not predict future returns. You may get back less than you originally invested. Reference to specific securities is not intended as a recommendation to purchase or sell any investment.

The Liontrust US Opportunities Fund returned 3.2% in the third quarter, outperforming both the S&P 500 Index return of 2.9% and the IA North America sector average return of 2.8% (both comparator benchmarks)*.

 

US equity markets continued to rally this quarter but were led by more defensive parts of the market as opposed to the more cyclical areas which dominated at the end of last year and the beginning of this. The dominant debate this year continues to be around inflation and whether the pick-up in inflation we have seen is transitory in nature or something more structural which will cause the Fed to tighten monetary policy quicker than otherwise might have been expected. One of the drivers of inflation has been the widely reported supply chain challenges and indeed US company earnings that were reported in the early part of this quarter began to show the impact. Supply chain challenges have included, amongst others, the shortage of semiconductor chips, logistics bottlenecks, labour shortages and subsequent wage pressure. Despite many of the companies we own, with strong pricing power, have looked to address this with price increases, these impacts are beginning to show up in their margins.

A related debate that has raged in recent months is whether the economic momentum that has been so strong in the US since the summer last year is already tailing off. The Delta Covid-19 wave has certainly slowed and in some cases reversed momentum in the re-opening of the US economy. The good news here is that by the end of September, it is looking likely that the US is past the worst of the Delta wave with the case count around a third lower than the Delta peak at the end of August and hospitalisations almost a quarter lower.

Concerns over whether the US was hitting the roadblocks, i.e. supply chain challenges, of such a strong recovery and some tepid jobs market reports, presumably complicated by the Delta wave and the ending of the US furlough program over the summer, meant that bond yields continued to retrace their steps for much of the quarter. At the end of March, 10-year Treasury yields had been as high as 1.75% but during August had touched 1.20%. However, the tune changed during the latter parts of September when the Fed essentially confirmed that they will look to start tapering QE in November and then once completed in 2022 will look to start raising interest rates at either the end of 2022 or early 2023. Yields finished the quarter a shade under 1.50%. 

The US Liontrust Opportunities Fund marginally outperformed the S&P 500 Index and the wider IA North America peer group during the quarter. As has been the case for a number of years now, the majority of the performance has been from stock specific factors. Strong performers included Horizon Therapeutics, which has continued to deliver strong results as it has transformed itself from a primary care pharma company to a full-fledged large cap biotech over the last few years. Another strong performer was HCA Healthcare, the largest non-government hospital operator in the US, which is currently benefiting from the recovery in post-COVID hospital volumes. In addition to this, HCA rallied during the three months after it boosted its revenue forecast for the full year, beating the average expectations.

On the other side of the ledger, our position in private security and protection company Brink’s was a detractor to returns over the quarter, with the company’s full year adjusted revenue forecast falling short of estimates. The company cites the persistence of the global pandemic as the primary driver behind lower-than-expected revenue in several key markets in Europe, North America and Latin America. However the company have addressed this by explaining that “despite a near-term revenue shortfall and the labour shortage in the U.S., we continue to expect 2022 percentage profit growth in the high teens as the pandemic subsides and revenue growth improves, driven by improvement initiatives in our core operations and initial results from our new digital solutions".

In terms of portfolio activity, we have made relatively minor changes to the portfolio and have been focusing our attention on companies and industries which we think we will structural beneficiaries of the post-Covid world. We continue to believe that disruption, and particularly digital disruption, will remain the most important determinant of corporate success. We continue to search for companies that we believe will be drivers of this disruption (disruptors), help fuel it (enablers) or indeed benefit from it (embracers). 

Discrete years' performance (%)**, to previous quarter-end:

 

Sep-21

Sep-20

Sep-19

Sep-18

Sep-17

Liontrust US Opportunities C Acc GBP

30.3

13.7

7.5

27.0

17.9

S&P 500

24.1

9.1

9.7

20.6

14.1

IA North America

25.4

9.1

7.4

19.3

14.6

Quartile

1

2

3

1

1

 

*Source: FE Analytics as at 30.09.21

 

**Source: FE Analytics as at 30.09.21. Quartiles generated on 06.10.21

  

Key Risks 
 
Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested. The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.
 
Investment in funds managed by the Global Equity (GE) team may involve investment in smaller companies - these stocks may be less liquid and the price swings greater than those in, for example, larger companies. Investment in funds managed by the GE team may involve foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The team may invest in emerging markets/soft currencies or in financial derivative instruments, both of which may have the effect of increasing volatility. Some of the funds managed by the GE team hold a concentrated portfolio of stocks, meaning that if the price of one of these stocks should move significantly, this may have a notable effect on the value of that portfolio.  

 

Disclaimer
 
This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 
 
This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust. Always research your own investments and if you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 
Understand common financial words and terms See our glossary
Global Equities

Related commentaries

See all related
Fund updates
Liontrust US Opportunities Fund Q1 2024 review
icon 8 May 2024
Liontrust Global Equities Team
Fund updates
Liontrust US Opportunities Fund Q4 2022 review
icon 27 January 2023
Global Equity
Fund updates
Liontrust US Opportunities Fund Q2 2022 review
icon 26 July 2022
Global Equity
Fund updates
Liontrust US Opportunities Fund Q1 2022 review
icon 28 April 2022
Global Equity
Fund updates
Liontrust US Opportunities Fund Q4 2021 review
icon 25 January 2022
Global Equity
Fund updates
Liontrust US Opportunities Fund Q3 2021 review
icon 20 October 2021
Global Equity

How to invest in Liontrust funds

Through a fund platform
Through a financial adviser
Direct with Liontrust